Oncology & Cancer

An epigenetic marker can predict survival in childhood leukaemia

A molecular epigenetic marker is important for distinguishing patients with childhood leukaemia at high and low risk of relapse even at the time of diagnosis. It can be important to adapt early on as to what treatment to ...

Oncology & Cancer

Breaking through a tumor's defenses

In research published today, Babraham Institute researchers have shown that some tumours use not one but two levels of protection against the immune system. Knocking out one level boosted the protective effects of the second ...

Oncology & Cancer

Researchers decipher the genome in chronic lymphocytic leukaemia

A team of researchers from University of Barcelona (UB) and their collaborators report for the first time the complete epigenome of chronic lymphocytic leukaemia, the most common type of leukaemia. The study, published in ...

Oncology & Cancer

Scientists map the genetic evolution of childhood leukaemia

The key genetic events responsible for initiating the early stages of a type of childhood leukaemia have been identified by scientists at The Institute of Cancer Research, London. Insights into the 'founder' genetic mutation ...

Oncology & Cancer

Making headway in infant leukemia research

Around 600 children under the age of 15 are diagnosed with leukaemia each year in Germany. The effects are especially dramatic if this severe illness develops at birth or shortly afterwards. Research carried out at the Division ...

page 7 from 17